Heart failure & cardiomyopathies

Epidemiology and Treatment of Heart Failure with Chronic Obstructive Pulmonary Disease in Canadian Primary Care

ESC Heart FailPublished Retrospective cohort study

Authors' conclusion

The prevalence of HF and COPD continues to rise. Although patients with either or both conditions are high utilizers of primary care, the majority of visits relate to non-cardiorespiratory comorbidities. Medical therapy for HF was similar and the initially lower beta-blocker utilization disappeared over time.

Study context

Population
All patients with Heart Failure (HF) or Chronic Obstructive Pulmonary Disease (COPD) in the Canadian Primary Care Sentinel Surveillance Network, 2010–2018population size in 2018
Participants
15,778 / 27,927 / 4,768
Exposure
HF alone vs COPD alone vs HF with COPD
  • HFn = 15,778
  • COPDn = 27,927
  • HF with COPDn = 4,768
Outcome
Age-sex-standardized prevalence per 100 population
Follow-up
2010 to 2018

Main finding

As reported in the abstract

HF alone prevalence increased

2.33 to 3.63

COPD alone prevalence increased

3.44 to 5.96

COPD with HF prevalence increased

12.70 to 15.67

Observational data: associations, not effects.

Further findings

Annual visit rates

COPD alone: high and stable
around 8
HF alone: declined
9.3-8.1, P = 0.04
Both conditions: declined
14.3-11.9, P = 0.006

Visit reasons

HF alone: CV visits
29.4%
HF alone: respiratory visits
3.5%
COPD alone: respiratory visits
16.4%
COPD alone: CV visits
11.3%
Concurrent disease: cardiorespiratory visits
39.0%
Majority of visits non-cardiorespiratory in HF alone and COPD alone

HF medical therapy, HF with vs without COPD

Beta-blocker use initially, COPD with HF vs HF alone
69.3% vs. 74.0%
Beta-blocker use by 2018, COPD with HF vs HF alone
74.5% vs. 73.5%
ACEi/ARB/ARNI use similar
MRA use marginally higher with concurrent COPD

Original publication

Epidemiology and Treatment of Heart Failure with Chronic Obstructive Pulmonary Disease in Canadian Primary Care. ESC Heart Fail. Published 3 October 2023. doi:10.1002/ehf2.14497

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.